> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# LabCorp Gains EUA for Covid Lineage Test
- URL: https://www.fdaweb.com/labcorp-gains-eua-for-covid-lineage-test/
- Published: 2022-06-10T12:00:00.000Z
- Updated: 2026-09-14T17:48:13.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152040

FDA has granted an emergency use authorization (EUA) for Laboratory Corp. of America’s VirSeq SARS-CoV-2 NGS Test on the PacBio Sequel II sequencing system. The test addresses the need to identify Covid-19 mutations that have resulted in genetic variation in circulating virus strains, also called lineages. It is the first test authorized for the identification and differentiation of SARS-CoV-2 Phylogenetic Assignment of Named Global Outbreak (PANGO) lineages. An [agency notice](https://content.govdelivery.com/accounts/USFDA/bulletins/31ba9f4?ref=fdaweb.com) says it is intended to be used when a health care provider decides, based on a patient’s medical history and other diagnostic information, that the test results may help in deciding the appropriate clinical care for a patient.